Regulatory T-cells and Crohn's Disease

NCT02060318 · clinicaltrials.gov ↗

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Infliximab

Sponsor

Hvidovre University Hospital